Oncogene inactivation in a mouse model.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

11 citing papers in PubMed.

1. Biology of chronic myeloid leukemia and possible therapeutic approaches to imatinib-resistant disease.International journal of hematology · 2004
   Review
2. Cell migration and metastasis as targets of small RNA-based molecular genetic analyses.Journal of muscle research and cell motility · 2004
   Review
3. Effective transduction and stable transgene expression in human blood cells by a third-generation lentiviral vector.Gene therapy · 2003
   Article
4. Identification of genes involved in cell invasion by using a library of randomized hybrid ribozymes.Proceedings of the National Academy of Sciences of the United States of America · 2003
   Article
5. A versatile communication module for controlling RNA folding and catalysis.Nucleic acids research · 2002
   Article
6. A functional gene discovery in the Fas-mediated pathway to apoptosis by analysis of transiently expressed randomized hybrid-ribozyme libraries.Nucleic acids research · 2002
   Article
7. Measurements of weak interactions between truncated substrates and a hammerhead ribozyme by competitive kinetic analyses: implications for the design of new and efficient ribozymes with high sequence specificity.Nucleic acids research · 2002
   Article
8. Identification of genes that function in the TNF-alpha-mediated apoptotic pathway using randomized hybrid ribozyme libraries.Nature biotechnology · 2002
   Article
9. Effective inhibition of herpes simplex virus 1 gene expression and growth by engineered RNase P ribozyme.Nucleic acids research · 2001
   Article
10. Significantly higher activity of a cytoplasmic hammerhead ribozyme than a corresponding nuclear counterpart: engineered tRNAs with an extended 3' end can be exported efficiently and specifically to the cytoplasm in mammalian cells.Nucleic acids research · 2001
    Article
11. RNA-protein hybrid ribozymes that efficiently cleave any mRNA independently of the structure of the target RNA.Proceedings of the National Academy of Sciences of the United States of America · 2001
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

6 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as